Dr. George Lowell, Md
Director
Director
BiondVax Pharmaceuticals Ltd.
Israel
Biography
Dr. George Lowell joined the Company in 2008. Dr. Lowell is the former Chief Scientific Officer of BioDefense at GlaxoSmithkline Biologicals and, prior to that, the CSO of ID Biomedical (subsequently acquired by GSK). He served as a Doctor (Consultant in Pediatric Infectious Diseases) and researcher at the Walter Reed General Hospital (US Army hospital) for 20 years. He subsequently founded and managed Intellivax, a vaccines R&D company that was acquired by ID Biomedical. Dr. Lowell has held a number of academic posts, including Visiting Scientist at the Weizmann Institute of Science (Israel) as well as Visiting Professor, Hebrew University-Hadassah Medical Center (Israel). Dr. Lowell is a Colonel (retired) in the US Army.
Research Interest
Dr. George Lowell joined the Company in 2008. Dr. Lowell is the former Chief Scientific Officer of BioDefense at GlaxoSmithkline Biologicals and, prior to that, the CSO of ID Biomedical (subsequently acquired by GSK). He served as a Doctor (Consultant in Pediatric Infectious Diseases) and researcher at the Walter Reed General Hospital (US Army hospital) for 20 years. He subsequently founded and managed Intellivax, a vaccines R&D company that was acquired by ID Biomedical. Dr. Lowell has held a number of academic posts, including Visiting Scientist at the Weizmann Institute of Science (Israel) as well as Visiting Professor, Hebrew University-Hadassah Medical Center (Israel). Dr. Lowell is a Colonel (retired) in the US Army.
